Transactions with Affiliate Company
Transaction with Affiliate Company
Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD) ("SEC"), on October 29, 2026, announced that its Board of Directors has authorized the following related-party transactions with affiliated companies.
1. Participation in rights offering
- Participation in the new stock issuance of Samsung Biologics ("Biologics")
□ Major transaction terms
|
Transaction items |
567,503 common shares of Biologics |
|
Transaction date |
November 17, 2026 |
|
Transaction value |
KRW 666.2 billion (total invested capital of KRW 2,665 billion) |
|
Purpose of transaction |
To purchase new shares issued by Biologics allotted to existing shareholders |
|
Terms and conditions |
- This transaction involves participation in the existing shareholders' subscription for the rights offering by Biologics, and it is disclosed as a large-scale internal transaction with a related party. - The transaction date is the scheduled payment date for the shares. - The transaction item represents 100% of the shares allotted to the existing shareholders. - The transaction value is based on the issue price per share in Biologics' Issue Price of New Shares in a Paid-in Capital Increase (Notice) on October 1, 2026. The amount is subject to change upon determination of the final issue price. - The total invested capital is SEC's cumulative investment in Biologics' including the transaction set forth herein. - The terms above are subject to changes in the process of Biologics' capital increase. - The CEO has been delegated authority to execute the detailed matters relating to this transaction. |
Other Information:
- Number of Independent Directors present at the Board of Directors meeting: 5
- Attendance of Audit Committee: Y
2. Purchase of savings-type insurance from Samsung Life Insurance
□ Major Transaction Terms
(Unit: KRW 100 million)
|
1. Name of insurance company |
Samsung Life Insurance Co., Ltd. |
Relationship with the Company |
Affiliate |
|
|
2. Insurance subscription date |
October 29, 2026 |
|||
|
3. Type of insurance |
Savings-type insurance |
|||
|
4. Insurance details |
a. Insurance premium |
50,000 |
||
|
b. Insurance proceeds |
- |
|||
|
c. Contract period |
3 years |
|||
|
d. Total premiums payable during the contract period |
50,000 |
|||
|
e. Insured property |
- |
|||
|
f. Premium payment method |
Lump-sum payment |
|||
|
g. Interest rate (%) |
4.25% (simple interest equivalent, after deducting expenses from premiums paid) |
|||
|
5. Date of Board resolution |
October 29, 2026 |
|||
|
6. Purpose of transaction |
To enhance profitability and ensure stable fund management |
|||
|
7. Other information |
- This transaction involves the subscription to a savings-type insurance product offered by Samsung Life Insurance (product name: Samsung Platinum Savings Insurance) |
|||
|
※Date of related disclosure |
- |
|||
Other Information:
- Number of Independent Directors present at the Board of Directors meeting: 5
- Attendance of Audit Committee: Y
3. Donation to Samsung Life Public Welfare Foundation
(Unit: KRW million)
|
1. Recipient |
Samsung Life Public Welfare Foundation, Social Welfare Corporation |
Relationship with the Company |
Non-profit organization |
|
2. Subject of donation |
Cash |
||
|
3. Donation amount |
24,430 |
||
|
4. Cumulative donation amount |
24,430 |
||
|
5. Date of donation |
- |
||
|
6. Date of Board resolution |
October 29, 2026 |
||
|
7. Total assets at the end of the previous fiscal year |
358,902,051 |
Percentage of Total Assets (%) |
0.01 |
|
8. Other information |
In item 5 above, the donation is scheduled to be made within 2026. In item 7 above, total assets at the end of the previous fiscal year are based on the Company's separate financial statements as of year-end 2025. |
||
|
※ Date of related disclosure |
- |
||
Other Information:
- Number of Independent Directors present at the Board of Directors meeting: 5
- Attendance of Audit Committee: Y
4. Donation to Sungkyunkwan University
(Unit: KRW million)
|
1. Recipient |
Sungkyunkwan University Foundation |
Relationship with the Company |
Non-profit organization |
|
2. Subject of donation |
Cash |
||
|
3. Donation amount |
38,690 |
||
|
4. Cumulative donation amount |
38,690 |
||
|
5. Date of donation |
- |
||
|
6. Date of Board resolution |
October 29, 2026 |
||
|
7. Total assets at the end of the previous fiscal year |
358,902,051 |
Percentage of Total Assets (%) |
0.01 |
|
8. Other information |
In item 5 above, the donation is scheduled to be made within 2026. The total assets at the end of the previous fiscal year under Item 7 are based on the Company's separate financial statements as of year-end 2025.
|
||
|
※ Date of related disclosure |
- |
||
Other Information:
- Number of Independent Directors present at the Board of Directors meeting: 5
- Attendance of Audit Committee: Y
5. Donation to Sungkyunkwan University Research & Business Foundation
(Unit: KRW million)
|
1. Recipient |
Sungkyunkwan University Research & Business Foundation |
Relationship with the Company |
Non-profit organization |
|
2. Subject of donation |
Cash and the right to use real estate free of charge
|
||
|
3. Donation amount |
11,800 |
||
|
4. Cumulative donation amount |
11,800 |
||
|
5. Date of donation |
- |
||
|
6. Date of Board resolution |
October 29, 2026 |
||
|
7. Total assets at the end of the previous fiscal year |
358,902,051 |
Percentage of Total Assets (%) |
0.003 |
|
8. Other information |
The donation amount under Item 3 is the sum of the cash contribution to the recipient (KRW 7.8 billion) and the value equivalent to the free use of buildings and ancillary facilities (approximately KRW 4.0 billion). Regarding the date of donation under Item 5, the Company plans to enter into an agreement with the recipient, make the cash payment, and provide access to the buildings and ancillary facilities within 2026. The total assets at the end of the previous fiscal year under Item 7 are based on the Company's separate financial statements as of year-end 2025. |
||
|
※ Date of related disclosure |
- |
||
Other Information:
- Number of Independent Directors present at the Board of Directors meeting: 5
- Attendance of Audit Committee: Y
6. Donation to the Korea Inclusive Finance Agency
(Unit: KRW million)
|
1. Recipient |
Korea Inclusive Finance Agency
|
Relationship with the Company |
Non-related party
|
|
2. Subject of donation |
Cash |
||
|
3. Donation amount |
150,000 |
||
|
4. Cumulative donation amount |
150,000 |
||
|
5. Date of donation |
- |
||
|
6. Date of Board resolution |
October 29, 2026 |
||
|
7. Total assets at the end of the previous fiscal year |
358,902,051 |
Percentage of total assets (%) |
0.04 |
|
8. Other information |
After receiving the funds specified in Item 3 above, the Korea Inclusive Finance Agency will transfer them to the Samsung Miso Finance Foundation, a related party of the Company. Regarding Item 5 above, the amount specified in Item 3 will be paid in installments over five years starting in 2026. The payment for 2026 is scheduled to be completed within 2026. The total assets at the end of the previous fiscal year under Item 7 are based on the Company's separate financial statements as of year-end 2025. |
||
|
※ Date of related disclosure |
- |
||
Other Information:
- Number of Independent Directors present at the Board of Directors meeting: 5
- Attendance of Audit Committee: Y
* Note: Pursuant to the Korea Fair Trade Act, a donor is required to disclose its donation to charitable organizations if such donation amount exceeds KRW 10 billion and the recipient is an affiliated entity of the donor.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE